title: Decreased expression of receptor tyrosine kinase of EphB1 protein in renal cell carcinomas.
abstract: Receptors tyrosine kinase of Eph superfamily plays an important role in human cancers. We previously found that EphB1 subtype is down-regulated in gastric cancer, colorectal cancer and ovary serous carcinoma. Fore the more, the decreased expression of EphB1 is related to invasion and metastasis in cancers. Although EphB1 has been revealed as an important receptor in cancers, our understanding of its roles in renal cell carcinoma (RCC) is limited. In the present study, using specific anit-EphB1 polyclonal antibody and immunohistochemistry, we evaluated EphB1 protein expression levels in RCC specimens surgically resected from 82 patients (including 62 conventional clear-cell RCC, 10 papillary, and 10 chromophobic RCC cases). We found EphB1 protein is positively expressed in the epithelium of renal tubules. Decreased expression of EphB1 was found in all RCC carcinomas compared with expression in the normal epithelium of renal tubules. EphB1 protein moderately expressed in chromophobic RCC, weakly expressed in clear-cell RCC and negatively expressed in papillary RCC. Our results indicate that EphB1 may be involved in carcinogenesis of RCC, the molecular mechanisms of down-regulation of EphB1 including genetic and epigenetic alterations and the dedicated roles of EphB1 in occurrence and progress of RCC need to be explicated in next step.
authors.affiliation: Department of Urology, Jinling Hospital, Nanjing University School of Medicine Nanjing 210002, P.R. China.
authors.forename: Shuigen
authors.initials: S
authors.lastname: Zhou
authors.affiliation: Department of Urology, Jinling Hospital, Nanjing University School of Medicine Nanjing 210002, P.R. China.
authors.forename: Longxin
authors.initials: L
authors.lastname: Wang
authors.affiliation: Deprtment of Pathology, 81 Hospital Nanjing 210002, P.R. China.
authors.forename: Guimei
authors.initials: G
authors.lastname: Li
authors.affiliation: Department of Urology, Jinling Hospital, Nanjing University School of Medicine Nanjing 210002, P.R. China.
authors.forename: Zhengyu
authors.initials: Z
authors.lastname: Zhang
authors.affiliation: Deprtment of Pathology, Jinling Hospital, Nanjing University School of Medicine Nanjing 210002, P.R. China.
authors.forename: Jiandong
authors.initials: J
authors.lastname: Wang
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis*; D002292:Carcinoma, Renal Cell / Q000378:metabolism* / Q000473:pathology; D015536:Down-Regulation; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007680:Kidney Neoplasms / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D036225:Receptor, EphB1 / Q000032:analysis / Q000096:biosynthesis*
chemical_list: D014408:Biomarkers, Tumor; D036225:Receptor, EphB1
keywords: EphB1; down-regulation; renal cell carcinoma